P

Prime Medicine, Inc.

214 employees

Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science
Gene Editing
Genetics
Medical

Date founded

2019

Funding rounds raised

Total raised

$200M

from 12 investors over 12 rounds

P

Prime Medicine, Inc. raised $200M on July 13, 2021

Investors: Newpath Partners, Casdin Capital, LLC, GV, F-Prime Capital Partners, T. Rowe Price, Samsara BioCapital and Redmile Group

P

Prime Medicine, Inc. raised $115M on October 22, 2019

Investors: Newpath Partners, GV, Arrive, ARCH Venture Partners and F-Prime Capital Partners

FAQ